HHS· @HHSGov · X·· 7 天前精选AI 评分52
AI 导读
美国卫生与公众服务部（HHS）在 X 上表示，FDA 提前数月批准了一款胰腺癌疗法，生存期较化疗翻倍。该帖引用 @FDA 的内容称，这是特朗普政府兑现加快审批、增加治愈手段承诺的体现，并附有《华盛顿观察家报》相关评论文章链接。HHS 正文称在总统领导下 FDA 正在变革癌症治疗，并引导读者查看 @FDA_KyleD 的更多内容。
正文
Faster Approvals = More Lives Saved
Under @POTUS' leadership, the FDA is revolutionizing cancer care and delivering cutting edge treatments for even the most aggressive forms of cancer.
Read more from @FDA_KyleD 👇
The Trump administration is delivering on its promise: faster approvals, more cures, stronger American biotech. The FDA approved a treatment for pancreatic cancer months ahead of schedule — doubling survival vs. chemo. https://www.washingtonexaminer.com/op-eds/4733623/pancreatic-cancer-fda-approval-rasonque-daraxonrasib-trump/在 X 查看被引用的帖子
来源：HHS · x.com